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Abstract: Tyrosinase is a multifunctional, glycosylated, and copper-containing oxidase, 
which catalyzes the first two steps in mammalian melanogenesis and is responsible for 
enzymatic  browning  reactions  in  damaged  fruits  during  post-harvest  handling  and 
processing. Neither hyperpigmentation in human skin nor enzymatic browning in fruits are 
desirable. These phenomena have encouraged researchers to seek new potent tyrosinase 
inhibitors for use in foods and cosmetics. This article surveys tyrosinase inhibitors newly 
discovered from natural and synthetic sources. The inhibitory strength is compared with 
that of a standard inhibitor, kojic acid, and their inhibitory mechanisms are discussed. 
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1. Introduction  
For the past few decades, tyrosinase inhibitors have been a great concern solely due to the key role 
of tyrosinase in both mammalian melanogenesis and fruit or fungi enzymatic browning. Melanogenesis 
has been defined as the entire process leading to the formation of dark macromolecular pigments, i.e., 
melanin. Melanin is formed by a combination of enzymatically catalyzed and chemical reactions. The 
biosynthetic pathway for melanin formation in various life forms has firstly been elucidated by Raper 
[1], Mason [2] and recently been modified by Cooksey et al. [3] and Schallreuter et al. [4] (Figure 1). 
Melanogenesis  is  initiated  with  the  first  step  of  tyrosine  oxidation  to  dopaquinone  catalyzed  by 
tyrosinase. This first step is the rate-limiting step in melanin synthesis because the remainder of the 
reaction  sequence  can  proceed  spontaneously  at  a  physiological  pH  value  [5].  The  subsequent 
dopaquinone is converted to dopa and dopachrome through auto-oxidation. Dopa is also the substrate 
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of  tyrosinase  and  oxidized  to  dopaquinone  again  by  the  enzyme.  Finally,  eumelanin  are  formed 
through a series of oxidation reactions from dihydroxyindole (DHI) and dihydroxyindole-2-carboxylic 
acid  (DHICA),  which  are  the  reaction  products  from  dopachrome.  In  the  presence  of  cysteine  or 
glutathione,  dopaquinone  is  converted  to  cysteinyldopa  or  glutathionyldopa.  Subsequently, 
pheomelanin  is  formed.  In  addition  to  eumelanin  and  pheomelanin,  other  “melanin”  relying  on 
phenolic monomers different from tyrosine is termed allomelanin. The browning phenomenon in fruit 
and fungi is also usually related to oxidative polymerization, conceptually similar to melanogenesis. 
The main difference resides in the fact that allomelanin substantially does not contain dopaquinone-
derived motifs as the main monomers in its structure and, on the contrary, is based on other quinoid 
building blocks. Melanin plays an important role in protecting human skin from the harmful effects of 
UV radiation from the sun. Melanin also determines our phenotypic appearance.  
Figure 1. Biosynthetic pathway of melanin [1-4]. TYR, tyrosinase; TRP; tyrosinase related 
protein;  dopa,  3,4-dihydroxyphenylalanine;  DHICA,  5,6-dihydroxyindole-2-carboxylic 
acid; DHI, 5,6-dihydroxyindole; ICAQ, indole-2-carboxylic acid-5,6-quinone; IQ, indole-
5,6-quinone; HBTA, 5-hydroxy-1,4-benzothiazinylalanine.  
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Although melanin has mainly a photoprotective function in human skin, the accumulation of an 
abnormal amount of melanin in different specific parts of the skin resulting in more pigmented patches 
might become an esthetic problem. In addition, enzymatic browning in fruit and fungi is undesirable in, 
for example,  fresh fruits, beverages, vegetables, and  mushrooms  [6]. Browning after harvest is a 
common phenomenon in crops  such as mushrooms, which decreases the commercial value of the  
products. Hyperpigmentation in human skin and enzymatic browning in fruits are not desirable. These 
phenomena  have  encouraged  researchers  to  seek  new  potent  tyrosinase  inhibitors  for  use  in Int. J. Mol. Sci. 2009, 10                       
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antibrowning  of  foods  and  skin  whitening.  Some  tyrosinase  inhibitors  have  been  discovered  and 
reviewed  before  [7-9];  this  article  surveys  tyrosinase  inhibitors  newly  discovered  from  natural  
and synthetic sources. 
On  the  other  hand,  knowledge  of  melanocyte  biology  and  the  processes  underlying  melanin 
synthesis  has  made  remarkable  progress  over  the  last  few  years,  opening  new  paths  in  the 
pharmacologic  approach  to  the  treatment  of  skin  hyperpigmentation.  In  addition  to  inhibition  
of  tyrosinase  catalytic  activity,  other  approaches  to  treat  hyperpigmentation  include  inhibition  of 
tyrosinase mRNA transcription, aberration of tyrosinase glycosylation and maturation, acceleration  
of  tyrosinase  degradation,  interference  with  melanosome  maturation  and  transfer,  inhibition  of 
inflammation-induced melanogenic response, and acceleration of skin turnover. Accordingly, a huge 
number of depigmenting agents or whitening agents developed by those alternative approaches have 
been  successfully  identified  and  deeply  reviewed  in  many  articles  [10-16].  Hence,  these 
multidirectional approaches to treat hyperpigmentation are not discussed in this review.  
2. Biochemical Characteristics and Reaction Mechanism of Tyrosinase  
A number of research papers and reviews have already been published on the structural and kinetic 
aspects  of  the  enzyme  tyrosinase  [17-22];  therefore,  under  this  section  I  will  briefly  discuss 
tyrosinase’s biochemical characteristics and reaction mechanism.  
Tyrosinases  (EC  1.14.18.1)  catalyze  the  oxidations  of  both  monophenols  (cresolase  or 
monophenolase  activity)  and  o-diphenols  (catecholase  or  diphenolase  activity)  into  reactive  
o-quinones.  The  term  tyrosinase  refers  to  its  typical  substrate,  tyrosine.  Both  tyrosinase  activities 
appear  to  have  broad  substrate  specificities,  although  the  enzyme  has  a  higher  affinity  for  the  
L-isomers of the substrates than for the corresponding D-isomers. The first biochemical investigations 
were carried out in 1895 on the mushroom Russula nigricans, whose cut flesh turns red and then black 
on exposure to air. Since this study, the enzyme has been found widely distributed throughout the 
phylogenetic scale from bacteria to mammals. The best-characterized tyrosinases are derived from 
Streptomyces  glausescens,  the  fungi  Neurospora  crassa  and  Agaricus  bisporus.  In  fungi  and 
vertebrates, tyrosinase catalyzes the initial step in the formation of the pigment melanin from tyrosine. 
In plants, the physiological substrates are a variety of phenolics. Tyrosinase oxidizes them in the 
browning pathway observed when tissues are injured. The enzyme extracted from the champignon 
mushroom A. bisporus is highly homologous with the mammalian ones, and this renders it well suited 
as a model for studies on melanogenesis. In fact, almost all studies on tyrosinase inhibition conducted 
so far have used mushroom tyrosinase because the enzyme is commercially available.  
The notable feature observed in tyrosinases from different sources is that the central copper-binding 
domain is conserved, which contains strictly conserved amino acid residues, including three histidines 
[17,23-24]. One tyrosinase molecule can contain two copper atoms, and each atom of the binuclear 
copper  cluster  is  ligated  to  three  histidines.  In  the formation  of  melanin pigments,  three  types  of 
tyrosinase (oxy-, met-, and deoxytyrosinase, Figure 2) with different binuclear copper structures of the 
active site are involved. The oxygenated form (oxytyrosinase, Eoxy) consists of two tetragonal copper 
(II) atoms, each coordinated by two strong equatorial and one weaker axial NHis ligand. The exogenous 
oxygen  molecule  is  bound  as  peroxide  and  bridges  the  two  copper  centers.  Mettyrosinase  (Emet), Int. J. Mol. Sci. 2009, 10                       
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similar  to  the oxy form, contains  two tetragonal copper (II) ions  coupled through an  endogenous 
bridge,  although  hydroxide  exogenous  ligands  other  than  peroxide  are  bound  to  the  copper  site. 
Deoxytyrosinase (Edeoxy) contains two copper (I) ions with a co-ordination arrangement similar to that 
of the met form, but without the hydroxide bridge. The resting form of tyrosinase, i.e., the enzyme as 
obtained after purification, is found to be a mixture of 85% met and 15% oxy forms. 
Figure 2. Catalytic cycles of the hydroxylation of monophenol and oxidation of o-diphenol 
to o-quinone by tyrosinase [23-24]. Eoxy, Emet, and Edeoxy are the three types of tyrosinase, 
respectively.  EoxyD,  EoxyM,  and  EmetM  are  Eoxy-Diphenol,  Eoxy-Monophenol,  and  Emet-
Monophenol complexes, respectively.  
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The  above  considerations  have  led  to  the  molecular  mechanism  for  the  monophenolase  and 
diphenolase activities of tyrosinase (Figure 2). In the monophenolase cycle, the monophenol can react 
only with the oxy form and be oxidized to the o-quinone, resulting in a deoxy form ready for further 
dioxygen  binding.  Oxytyrosinase  is,  then,  regenerated  after  the  binding  of  molecular  oxygen  to 
deoxytyrosinase. If only o-diphenol is present (the diphenolase cycle), both the oxy and met forms 
react with o-diphenol, oxidizing it to the o-quinone. o-Diphenol binds to the oxy form and is oxidized 
to o-quinone, yielding the met form of the enzyme. The latter form transforms another o-diphenol 
molecule into o-quinone and is reduced to the bicuprous deoxy form. In most situations, a diphenol is 
necessary  as  the  reducing  agent  to  obtain  the  deoxy  form,  the only one  capable of reacting  with 
molecular oxygen and continuing in the catalytic action. For this reason, the monophenolase activity 
presents a characteristic lag time that exists until a sufficient amount of catechol (needed to reduce the 
met form to the deoxy one) is produced by the small amount of the oxy form generally present in the 
resting enzyme preparations. The length of the lag time depends on several factors: the enzyme source; 
the  concentration  of  monophenol  (the  lag  period  being  longer  when  monophenol concentration  is 
increased); the enzyme concentration (with the lag period diminishing, but never totally disappearing, Int. J. Mol. Sci. 2009, 10                       
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when  the  enzyme  concentration  is  increased);  and  finally,  the  presence  of  catalytic  amounts  of  
o-diphenol or transition metal ions, which completely abolish the lag period.  
3. Tyrosinase Inhibitors 
A number of tyrosinase inhibitors from both natural and synthetic sources have been identified. 
However,  the  definition  of  “tyrosinase  inhibitor”  is  sometimes  misleading:  many  authors  use  that 
terminology  in  reference  to  melanogenesis  inhibitors,  whose  action  mainly  resides  in  some 
interference in melanin formation, regardless of any direct inhibitor/enzyme interaction. Many putative 
inhibitors are examined in the presence of tyrosine or dopa as the enzyme substrate, and activity is 
assessed  in  terms  of  dopachrome  formation.  Thus,  experimental  observation  of  the  inhibition  of 
tyrosinase activity can be accomplished by one of following:  
(1) Reducing agents causing chemical reduction of dopaquinone such as ascorbic acid, which is 
used as a melanogenesis inhibitor because of its capacity to reduce back o-dopaquinone to dopa, thus 
avoiding dopachrome and melanin formations.  
(2)  o-Dopaquinone  scavenger  such  as  most  thio-containing  compounds,  which  are  well-known 
melanogenesis inhibitors and react with dopaquinone to form colorless products. The melanogenetic 
process is therefore slowed until all the scavenger is consumed, and then it goes at its original rate.  
(3)  Alternative  enzyme  substrates  such  as  some  phenolic  compounds,  whose  quinoid  reaction 
products absorb in a spectral range different from that of dopachrome. When these phenolics show a 
good  affinity  for  the  enzyme,  dopachrome  formation  is  prevented,  and  they  could  be  mistakenly 
classified as inhibitors.  
(4) Nonspecific enzyme inactivators such as acids or bases, which non-specifically denature the 
enzyme, thus inhibiting its activity.  
(5)  Specific  tyrosinase  inactivators  such  as  mechanism-based  inhibitors,  which  are  also  called 
suicide substrates. These inhibitors can be catalyzed by tyrosinase and form covalent bond with the 
enzyme, thus irreversibly inactivating the enzyme during catalytic reaction. They inhibit tyrosinase 
activity by inducing the enzyme catalyzing “suicide reaction.”  
(6) Specific tyrosinase inhibitors such as most compounds discussed in this review. The compounds 
reversibly bind to tyrosinase and reduce its catalytic capacity.  
Among the six types of compounds described above, only specific tyrosinase inactivators (5) and 
inhibitors  (6) are  regarded  as  “true  inhibitors,” which  actually  bind to the enzyme and inhibit its 
activity. General speaking, the mistaken inhibitors exhibit only weak inhibitory activity due to their 
reactive  and  consumable  properties  toward  the  enzyme  or  the  quinone  products.  Although  some 
tyrosinase  inhibitors  exhibited  multifunctional  activities,  the  compounds,  which  are  well-known 
reductive agents, dopaquinone scavengers, or tyrosinase substrates and do not obviously belong to the 
true  inhibitors,  are  not  suitable  for  comparison  with  the  true  inhibitors  and  are  ignored  in  the  
present article.  
Usually,  “true  inhibitors”  are  classified  into  four  types,  including  competitive  inhibitors, 
uncompetitive  inhibitors,  mixed  type  (competitive/uncompetitive)  inhibitors,  and  non-competitive 
inhibitors (Scheme 1). A competitive inhibitor is a substance that combines with a free enzyme in a 
manner that prevents substrate binding. That is, the inhibitor and the substrate are mutually exclusive, Int. J. Mol. Sci. 2009, 10                       
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often because of true competition for the same site. A competitive inhibitor might be a copper chelator, 
non-metabolizable analogs, or derivatives of the true substrate. In contrast, an uncompetitive inhibitor 
can bind only to the enzyme-substrate complex. A mixed (competitive and uncompetitive mixed) type 
inhibitor can bind not only with a free enzyme but also with the enzyme-substrate complex. For most 
mixed-type  inhibitors,  their  equilibrium  binding  constants  for  the  free  enzyme  and  the  enzyme-
substrate complex, respectively, are different. However, a special case among the mixed inhibitors is 
the non-competitive inhibitors, which bind to a free enzyme and an enzyme-substrate complex with the 
same equilibrium constant. In addition to the inhibitory mechanism, inhibitory strength is the primary 
criterion of an inhibitor. Inhibitor strength is usually expressed as the inhibitory IC50 value, which is 
the concentration of an inhibitor needed to inhibit half of the enzyme activity in the tested condition. 
However, for the tyrosinase inhibitors in the literature, the IC50 values are incomparable due to the 
varied  assay  conditions,  including  different  substrate  concentrations,  varied  incubation  time,  and 
different batches of commercial tyrosinase. Fortunately, in most studies conducted to discover new 
tyrosinase inhibitors, a well-known tyrosinase inhibitor such as kojic acid is often used as a positive 
standard at the same time. Hence, in order to compare the inhibitors described in different literature in 
a more practical manner, a relative inhibitory activity (RA), which is calculated by dividing the IC50 
value of kojic acid with that of a newly found inhibitor in the same report, is used to express and 
compare the inhibitory strength of an inhibitor with others in this review.  
Scheme  1.  Action  mechanism  of  reversible  inhibitors.  E,  S,  I,  and  P  are  the  enzyme, 
substrate, inhibitor, and product, respectively; ES is the enzyme-substrate complex, and EI 
and ESI are the enzyme-inhibitor and enzyme-substrate-inhibitor complexes, respectively. 
 
Kojic acid (Figure 3a), the most intensively studied inhibitor of tyrosinase, is a fungal metabolite 
currently used as a cosmetic skin-whitening agent and as a food additive for preventing enzymatic 
browning [25]. Kojic acid shows a competitive inhibitory effect on monophenolase activity and a 
mixed inhibitory effect on the diphenolase activity of mushroom tyrosinase. The ability of kojic acid to 
chelate copper at the active site of the enzyme may well explain the observed competitive inhibitory 
effect. In addition, kojic acid is reported to be a slow-binding inhibitor of the diphenolase activity of 
tyrosinase [26]. This means that the active form of tyrosinase, generated in the catalytic cycle in the 
presence of the substrate, is required before binding of the inhibitor to the enzyme can occur. Other 
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slow-binding inhibitors of tyrosinase are the very potent inhibitor tropolone [27] and the substrate 
analog L-mimosine [28] (Figure 3a). Strikingly, these slow-binding inhibitors of tyrosinase all contain 
an -hydroxyketone group. Kojic acid together with tropolone and L-mimosine are often used as the 
positive control in the literature for comparing the inhibitory strength of the finding inhibitors.  
In addition to the standard tyrosinase inhibitors, a huge number of new inhibitors, especially for 
those discovered in the last five years, are collected in this review and classified into five major classes, 
including polyphenols, benzaldehyde and benzoate derivatives, long-chain lipids and steroids, other 
natural or synthetic inhibitors, and irreversible inactivators based on either the chemical structures or 
the inhibitory mechanism.  
3.1. Polyphenols 
Polyphenols represent a diverse group of compounds containing multiple phenolic functionalities 
and are widely distributed in nature. Polyphenols are also the largest groups in tyrosinase inhibitors 
until  now.  Since  several  polyphenols  are  accepted  as  substrates  by  tyrosinase,  it  depends  on  the 
presence  and  position  of  additional  subsistent  whether  a  polyphenol  may  act  as  an  inhibitor. 
Flavonoids  are  among  the  most  numerous  and  best-studied  polyphenols,  that  is,  benzo--pyrone 
derivatives consisting of phenolic and pyrene rings. Widely distributed in the leaves, seeds, bark, and 
flowers of plants, more than 4,000 flavonoids have been identified to date. In plants, these compounds 
give protection against UV radiation, pathogens, and herbivores [29]. They are also responsible for the 
characteristic  red  and  blue  colors  of  berries,  wines,  and  certain  vegetables.  Flavonoids  may  be 
subdivided into seven major groups, including flavones, flavonols, flavanones, flavanols, isoflavonoids, 
chalcones,  and  catechin.  Different  classes  of  flavonoids  are  distinguished  by  additional  oxygen-
heterocyclic rings, by positional differences of the B ring, and by hydroxyl, methyl, isoprenoid, and 
methoxy groups distributed in different patterns about the rings. The structure of flavonoids is also in 
principle  compatible  with  the  roles  of  both  substrates  and  (presumably  competitive)  inhibitors  of 
tyrosinase. Detailed studies have shown that some flavonoids are in fact rather potent inhibitors and 
discussed in this section. In addition to flavonoids, other polyphenols, which were also identified as 
tyrosinase inhibitors, contain stilbenes and coumarin derivatives.  
 
Flavonols. Many flavonols have been isolated from plants, and some were identified as tyrosinase 
inhibitors.  The  inhibitory  mode  of  flavonol  inhibitors  is  usually  competitive  inhibition  for  the 
oxidation of L-dopa by tyrosinase and the 3-hydroxy-4-keto moiety of the flavonol structure acts as the 
key role in copper chelation [30-31]. In terms of inhibitor strength, the discovered flavonol inhibitors 
are  ranking  as  follows:  quercetin  (5,7,3',4'-tetrahydroxyflavonol)  >  myricetin  (5,7,3',4',5'-
pentahydroxy-flavonol)  >  kaempferol  (5,7,4'-trihydroxyflavonol)  >  galangin  (5,7-
dihydroxyflavonol)  >>  morin,  buddlenoid  A,  buddlenoid  B  [32-33].  In  addition,  the  flavonol 
glycosides of quercetin or kaempferol were found to be less active than their corresponding aglycones 
[34].  Recently,  6-hydroxykaempferol  was  synthesized  and  confirmed  to  possess  two  times  more 
activity than kaempferol [35]. Although many flavonols have been identified as tyrosinase inhibitors, 
all the flavonol inhibitors listed above are very weak inhibitors; the most active flavonol, quercetin 
(Figure 3b), showed only 20% of the inhibitory strength of kojic acid toward diphenolase activity of Int. J. Mol. Sci. 2009, 10                       
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mushroom  tyrosinase.  Hence,  it  is  obvious  that  these  flavonol  inhibitors  have  little  potential  in 
applications of skin whitening or food antibrowning.  
Figure 3. Chemical structures of selected tyrosinase inhibitors belonging to some standard 
ones (a), flavonoids (b-j) or N-benzylbenzamides analogs (k). RA
a and RA
b are the relative 
diphenolase  and  monophenolase  inhibitory  activity,  respectively,  against  mushroom 
tyrosinase compared to the standard kojic acid, where 1.0F means one time activity of 
kojic acid.  
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(Competitive; RAb, 13.6F; ref.41)
(e) Flavanols
Dihydromorin
(RAb, 0.5F; ref.43)
Taxifolin
(RAb, 1.0F; ref.46)
O O
OH
OH
O
OH
R2
R3
R1 O
O H O
O
OH
OMe
O H
(g) Isoflavans
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(Non-competitive; RAb, 15.2F; ref.51)
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(RAb, 27.7F; ref.51)
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(h) Isoflavones
Calycosin
(RAb, 1.3F; ref.57)
6-Hydroxydaidzein: R1=R3=H, R2=OH
(Competitive; RAb, 6.0F; ref.53)
8-Hydroxydaidzein: R1=R2=H, R3=OH
(Suicide substrate; ref.54)
8-Hydroxygenistein: R1=R3=OH, R2=H
(Suicide substrate; ref.54)
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(i) Chalcones
2,4,2',4'-Tetrahydroxychalcone: R=H
(Competitive; RAb, 2.5F; ref.66)
2,4,6,2',4'-Pentahydroxychalcone: R=OH
(Competitive; RAb, 12.0F; ref.66)
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O
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(j) Prenylated Chalcones
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(RAb, 34.1F; ref.59)
Kuraridinol
(Non-competitive; RAb, 18.4F; ref.60)
(k) N-Benzylbenzamides
N
H
O
R1
R2
R3
R4
R5
OH
3,5,2',4'-Tetrahydroxyl derivatives: R1=R3=H, 
R2=R4=R5=OH (RAa, 7.4F; ref.67)
2,4,2',4'-Tetrahydroxyl derivatives: R1=R3=R5=OH, 
R2=R4=H (RAa, 0.6F; ref.67)
3,5,4'-Trihydroxyl derivatives: R1=R3=R5=H, 
R2=R4=OH (RAa<<0.1F; ref.67)
2,4,4'-Trihydroxyl derivatives: R1=R3=OH, 
R2=R4=R5=H (RAa<<0.1F; ref.67)  
 Int. J. Mol. Sci. 2009, 10                       
 
 
2448 
Flavones, flavanones, and flavanols. Citrus peel as a by-product of the citrus juice industry contains a 
large amount of flavonoids. Some of the flavonoids were identified as tyrosinase inhibitors, including 
nobiletin (5,6,7,8,3',4'-hexamethoxyflavone), naringin (5,7,4'-trihydroxyflavanone), and neohesperidin 
(5,7,3'-trihydroxy-4'-methoxyflavone).  However,  the  inhibitory  strength  of  the  three  inhibitors  was 
found to be poorly active toward mushroom tyrosinase compared with kojic acid [36-37]. Although no 
potent tyrosinase inhibitors have been isolated from citrus fruit until now, the ethanolic extract of 
citrus  fruit  exhibited  in  vitro  inhibitory  effects  on  melanogenesis  in  melanoma  cells  and  in  vivo 
prevention against UVB-induced pigmentation of dorsal skin in brown guinea pigs. The melanogenesis 
inhibitory activity of citrus crude extracts was found to be mainly attributed to the antioxidant activity 
of neohesperidin in citrus fruit.  
 
In addition to citrus extracts, the extracts from Morus species, which has been well-known as a 
polyphenol-rich plant and used as a non-toxic natural therapeutic agent, also have high potential in 
applications as skin-whitening agents due to many potent tyrosinase inhibitors being isolated from 
different parts of the plant. Mulberroside F (moracin M-6,3'-di-O--glucopyranoside) purified from the 
leaves of the plant showed the antidiphenolase activity of mushroom tyrosinase to be 4.5-fold higher 
than that of kojic acid and exhibited an inhibitory effect on melanin formation within melanoma cells 
[38]. Norartocarpetin (5,7,2',4'-tetrahydroxyflavone, Figure 3c), isolated from the stem bark of the 
plant,  was  found  to  be  10.4-fold  more  active  than  kojic  acid  against  monophenolase  activity  of 
mushroom tyrosinase with a competitive inhibition mode (KI = 1.35 M) [39]. The flavone was also 
demonstrated to be a slow-binding inhibitor just like kojic acid and tropolone. In addition to the leaves 
and stem of the plant, the roots of the Morus species were also found to contain many very potent 
tyrosinase  inhibitors,  including  oxyresveratrol  [40],  norartocarpetin,  and  streppogenin  (5,7,2',4'-
tetrahydroxy-flavavone, Figure 3d) [41]. Oxyresveratrol is a hydroxystilbene with trans configuration, 
and its inhibitory property will be discussed in the later “silbenes” section. The chemical structure of 
streppogenin (a flavanone) is very similar to that of norartocarpetin (a flavone) with the same four 
substituted hydroxyl groups. It is reasonable that streppogenin possesses an inhibitory property similar 
to  that  of  norartocarpetin  including  similarly  inhibitory  strength  on  monophenolase  activity  
(IC50 = 0.57 and 0.47 M, respectively) and the same slow-binding and competitive inhibition mode 
(KI = 0.7 and 0.6 M, respectively) against mushroom tyrosinase. Moreover, the two potent inhibitors, 
together  with  another  two  analogs,  dihydromorin  (5,7,2',4'-tetrahydroxyflavanol,  Figure  3e)  and 
artocarpetin (5,2',4'-trihydroxy-7-methoxyflavone, Figure 3c), were recently isolated from the wood of 
Artocarpus heterophyllus [42-43].  
It  is  very  interesting  to  compare  the  inhibitory  strength  toward  monophenolase  activity  of 
mushroom tyrosinase among the four analogs described above. First, it was found that methoxylation 
of the hydroxyl group at the C7 position of the flavone skeleton revealed a  100-fold decrease in 
inhibitory activity by comparing the inhibitory strength between artocarpetin and norartocarpetin. In 
fact, for most tyrosinase inhibitors, glycosylation and methoxylation of the specific hydroxyl group on 
the aromatic ring would heavily affect exerting their inhibitory activity. Similar results were also found 
that forty-five flavonoids glycosides were recently isolated from Marrubium species, and all exhibited 
very low tyrosinase inhibitory activity [44]. The reasons for causing the decreased inhibitory activity 
by glycosylation and methoxylation of flavonoids include the loss of the specific hydroxyl group, Int. J. Mol. Sci. 2009, 10                       
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which plays a key role in showing the inhibition and formation of the hydrophilic and stereohindrance 
effects of the bulky glycoside moiety, which prevent the inhibitor from fitting into the active site of the 
enzyme.  Second,  it  has  been  mentioned  that  norartocarpetin  and  streppogenin  have  very  similar 
inhibitory activity and mode toward mushroom tyrosinase. In contrast, dihydromorin, which contains 
an extra 3-hydroxy group and hence belongs to the flavanol class of flavonoids, exhibited a 20-fold 
decrease in inhibitory activity compared with that of streppogenin and norartocarpetin. As described in 
the  “flavonol”  section, it has been demonstrated that the  3-hydroxy-4-keto moiety in the flavonol 
inhibitors  acts  as  the key role  in  copper chelation, and  loss of the group will  completely abolish 
inhibitory  activity  [31].  Based  on  the  mechanism,  it  is  difficult  to  explain  the  lowered  inhibitory 
capacity of dihydromorin, which contains the 3-hydroxy group and thus forms the 3-hydroxy-4-keto 
moiety in its structure. Although the 3-hydroxy-4-keto moiety of dihydromorin could form the copper 
chelating capacity, it seems that the extra 3-hydroxy group in dihydromorin had more drawbacks on 
tyrosinase inhibition. According to this, the criteria for tyrosinase inhibition by the flavonoids become 
an interesting issue. Especially, the effects of both the numbers and the positions of hydroxyl groups 
attached to the flavonoids skeletons on the inhibitory activity of mushroom tyrosinase are the main 
concern. Kim et al. recently systematically tested a large number of flavonoids with different numbers 
and positions of hydroxyl groups using the fluorescence quenching spectroscopic method [45]. Both 
the tyrosinase inhibitory activities and copper chelating capacities of the flavonoids were evaluated in 
the work. From the results, the authors concluded that the enzyme tyrosinase is primarily quenched by 
the hydroxyl groups of A and B rings on the ether side of the flavonoids (C6 to C8 and C2’ to C4’). 
According  to  the  finding,  the  extra  3-hydroxyl  group  of  dihydromorin  would  indeed  reduce  its 
inhibitory activity compared to streppogenin due to the 3-hydroxyl group making dihydromorin more 
difficult  to  form  a  binding  complex  with  the  enzyme.  Their  result  could  also  explain  that  most 
flavonols or flavanols inhibitors exhibited only weak to moderate inhibitory strength.  
Another flavanol, taxifolin (5,7,3',4'-tetrahydroxyflavanol, Figure 3e) isolated from the sprout of 
Polygonum hydropiper, showed equal inhibitory activity of kojic acid toward monophenolase activity 
of  mushroom  tyrosinase  [46].  In  an  advance  study,  it  is  interesting  to  find  that  taxifolin  would 
effectively  inhibit  both  the  tyrosinase  activity  of  the  living  cells  and  cellular  melanogenesis  as 
effectively as arbutin, despite its effects on increasing the tyrosinase protein level [47]. In addition to 
flavonoid  monomers,  one  flavone-flavanone  dimmer  was  isolated  from  seashore  plants,  Garcinia 
subelliptica,  and  revealed  to  be  3.6-fold  more  active  than  kojic  acid  against  the  monophenolase 
activity of mushroom tyrosinase [48].  
 
Isoflavonoids. The extracts from the roots and seeds of Glycyrrhiza species (Leguminoseae) have long 
been  regarded  as  an  effective  constituent  for  skin-whitening  agents  in  East  Asian  countries.  The 
melanogenesis inhibitory activity of the extracts mainly comes from the isoflavonoids in the plant. 
Two isoflavans were purified from the roots of the plant and identified as potent tyrosinase inhibitors. 
Glabridine  (Figure  3g)  was  the  first  confirmed  inhibitor  with  15  times  activity  of  kojic  acid  and 
exhibited  higher  depigmenting  activity  than  that  of  arbutin  [49].  In  contrast,  glabridine’s  analog, 
glabrene,  was  found  to  be  100-fold  less  active  than  glabridine  [50].  Kinetics  study  showed  that 
glabridin  and  glabrene  inhibited  the  enzyme  with  non-competitive  and  uncompetitive  modes, 
respectively. Glyasperin C (Figure 3g) was recently isolated from the same part of the plant and shown Int. J. Mol. Sci. 2009, 10                       
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to be two times more active than glabridin [51]. Although glyasperin C is the most active inhibitor, 
glabridin had the best melanogenesis inhibitory activity among them.  
 
On the other hand, we isolated several isoflavones derivatives from soybean koji fermented with 
Aspergillus oryzae and demonstrated three hydroxyisoflavones including 6-hydroxydaidzein (6,7,4'-
trihydroxyisoflavone),  8-hydroxydaidzein  (7,8,4'-trihydroxyisoflavone),  and  8-hydroxygenistein 
(5,7,8,4'-tetrahydroxyisoflavone)  as  potent  tyrosinase  inhibitors  (Figure  3h)  [52-53].  Among  them,  
6-hydroxydaidzein with 6-fold more than kojic acid acts competitively on the L-tyrosine binding site 
of the enzyme while the other two 8-hyroxyisoflavones irreversibly inactivate the enzyme and belong 
to the suicide substrates of tyrosinase (discussed in the “irreversible inactivators” section) [54]. It is 
interesting to note that the position and number of hydroxyl groups in the A ring of the isoflavone 
structure can strongly affect both the inhibitory strength and the inhibitory mode of the isoflavones to 
mushroom  tyrosinase.  For  example,  an  isoflavone  with  hydroxyl  groups  at  both  the  C6  and  C7 
positions  in  the  A  ring  (6,7,4'-trihydroxyisoflavone)  would  increase  more  than  10  times  both  the 
inhibitory activity (judged by IC50 values) and affinity to the enzyme (judged by Michaelis constants) 
compared to that of isoflavones either with only one hydroxyl group at the C7 position  or without any 
hydroxyl group in the A ring. Alternatively, the hydroxyl groups at both the C7 and C8 positions 
(7,8,4'-trihydroxyisoflavone  and  5,7,8,4'-tetrahydroxyisoflavone)  would  completely  change  the 
inhibitory mode of the isoflavones from the reversible competitive to the irreversible suicide form. The 
elucidation  of  the  detailed  mechanism  of  the effects  of the hydroxyl groups  in  the  A ring in  the 
isoflavones structure on their inhibitory activity toward tyrosinase needs further study. 
In addition to the isoflavonoids from Glycyrrhiza plants, Lee et al. recently identified other natural 
isoflavonoids as potent tyrosinase inhibitors. Haginin A (2',3'-dimethoxy-7,4'-dihdroxyisoflav-3-ene, 
Figure 3f) isolated from the branch of Lespedeza cyrtobotrya was shown to be 10-fold more active 
than kojic acid against monophenolase activity of mushroom tyrosinase with a non-competitive mode 
[55]. The compound significantly inhibited melanin synthesis in melanoma cells and decreased UV-
induced  skin  pigmentation  in  brown  guinea  pigs.  Furthermore,  haginin  A  presented  remarkable 
inhibition  on  the  body  pigmentation  in  the  zebrafish  model  system.  Dalbergioidin  (5,7,2',4'-
tetrahyroxyisoflavan)  was  also  isolated  from  L.  cyrtobotrya  and  non-competitively  inhibited  the 
monophenolase  activity  of  mushroom  tyrosinase  [56].  Fifty  percent  of  melanin  biosynthesis  in 
melanoma cells was inhibited by 27 M of dalbergioidin, and 80% of cell viability was maintained in 
this concentration. The third potent inhibitor discovered by the authors is calycosin (4'-methoxy-7,4'-
dihydroxyisoflavone,  Figure  3h),  which  showed  slighter  higher  monophenolase  inhibitory  activity 
toward  mushroom  tyrosinase  than  that  of  kojic  acid.  The  compound  contains  two  mechanisms  to 
reduce melanogenesis in melanoma cells, including inhibiting tyrosinase activity and reducing  the 
expression of tyrosinase [57].  
 
Chalcones. Chalcones consist of two aromatic rings in trans configuration, separated by three carbon 
atoms, of which two are connected by a double bond and the third is a carbonyl group. Some natural 
prenylated  chalcones  showed  potent  tyrosinase  inhibitory  activity.  Three  chalcones  derivatives, 
including licuraside, isoliquiritin, and licochalcone A were isolated from the roots of the Glycyrrhiza 
species and competitively inhibited the monophenolase activity of mushroom tyrosinase. Among them, Int. J. Mol. Sci. 2009, 10                       
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licochalcone A (Figure 3j) was 5.4-fold more active than kojic acid [58]. Another prenylated chalcone, 
kuraridin  (Figure  3j),  was  isolated  from  the  plant  Sophora  flavescens  and  identified  as  a  potent 
tyrosinase  inhibitor,  which  was  34  times  activity  of  kojic  acid  against  monophenolase  activity  of 
mushroom tyrosinase [59]. Following, its hydroxyl analog, kuraridinol (Figure 3j), was found to be 
18.4-fold more active compared to kojic acid [60]. More interesting, the two prenylated chalcones 
exhibited significantly more activity than those of their corresponding flavanone analogs. Kuraridin (a 
chalcone) is 10-fold more active than kurarinone (a flavanone) while kuraridinol (a chalcone) is also 
10-fold more active than kurarinol (a flavavone). This emphasizes that tyrosinase inhibitors with a 
chalcone structure have enhanced potential. Recently, 2,4,2',4'-tetrahydroxy-3-(3-methyl-2-butenyl)-
chalcone (TMBC, Figure 3j), which was isolated from the stems of Morus nigra, was proved to be  
26-fold more potent than kojic acid in diphenolase inhibitory activity of mushroom tyrosinase [61]. 
The kinetic study showed that the compound is competitive to the L-dopa binding site of the enzyme 
with a KI value of 1 to 1.5 M. Moreover, the melanin content of melanoma cells was reduced to 31% 
by 30 M of TMBC treatment. The inhibitory effect of TMBC on melanogenesis was attributed to the 
direct inhibition of tyrosinase activity, rather than suppression of tyrosinase gene expression.  
 
From  the  naturally  found  chalcones  listed  above,  it  seems  that  the  4-resorcinol  moiety  (2,4-
dihydroxyl  groups  in  the  aromatic  ring)  in  the  chalcone  structure  is  the  key  substituted  group  in 
exerting  potent  inhibitory  activity.  Some  simple  4-alkylresorcinols  were  proved  to  exhibit  strong 
tyrosinase  inhibitory  activity  [62-63].  To  evaluate  the  structure-activity  relationship  between  the 
numbers and the positions of hydroxyl groups in the chalcone skeleton and the inhibitory activity 
toward mushroom tyrosinase, the inhibitory activity against mushroom tyrosinase of many chemically 
synthesized  hydroxychalcones  was  examined.  In  an  early  study,  Nerya  et  al.  reported  that  the  
4-hydroxyl group in the B ring of the chalcone skeleton is the major factor affecting inhibitory potency, 
because it results in a molecular skeleton closely similar to that of L-tyrosine [64]. Following, they 
found  that  2,4,2',4'-tetrahydroxychalcone  (Figure  3i)  possesses  the  most  potent  monophenolase 
inhibitory  activity  compared  with  3,4,2',4'-tetrahydroxychalcone  and  2,4,3',4'-tetrahydroxychalcone 
[65]. Therefore, they concluded that 4-resorcinol moiety in the chalcone skeleton plays the key role in 
exhibiting  inhibitory  potency.  Similarly,  Jun  et  al.  recently  chemically  synthesized  a  series  of 
hydroxychalcones  and  determined  the  tyrosinase  inhibitory  activity  [66].  The  results  were  also 
consistent  with  that  by  Nerya  et  al.  Moreover,  they  found  that  2,4,2',4',6'-pentahydroxychalcone 
(Figure  3i)  is  5-fold  stronger  than  2,4,2',4'-tetrahydroxychalcone.  The  inhibitory  mode  of  the 
compound is also competitive to the L-tyrosine binding site of the enzyme with a KI value of 3.1 M. 
On the other hand, as seen in the description in the earlier “flavone” section, it is interesting to note 
that the identified potent tyrosinase inhibitors with a flavone, flavanone, or flavonol skeleton such as 
artocarpetin,  norartocarpetin,  and  streppogenin  all  contain  4-resorcinol  in  the  B  ring.  Thus,  the  
4-resorcinol  moiety  plays  an  important  role  in  the  inhibition  of  tyrosinase  activity  not  only  in 
chalcones but also in other flavonoid structures. 
In similar research with N-benzylbenzamide as the structure skeleton, which is analogous to that of 
chalcone but with an amide moiety (not the alkyl double bond) connecting between the two aromatic 
rings, the inhibitory activities of N-benzylbenzamide derivatives (Figure 3k) were found to rank by 
3,5,2',4'-tetrahydroxyl > 2,4,2',4'-tetrahydroxyl > 3,5,4'-trihydroxyl > 2,4,4'-trihydroxyl substitutions Int. J. Mol. Sci. 2009, 10                       
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[67]. Accordingly, it was concluded that the 4-resorcinol in the B ring has more effect than in the A 
ring on exerting potent inhibitory activity, while the 5-resorcinol in the A ring is preferred to the 4-
resorcinol. Very interesting, the structural criterion for exerting potent tyrosinase inhibitory activity in 
the chalcone-like structure, i.e., the 4-resorcinol moiety in the B ring and the 5-resorcinol in the A ring, 
is partially consistent with that in the flavone structure studied by the previous fluorescence quenching 
spectroscopic method, i.e., the hydroxyl groups of A and B rings on the ether side of the flavones  
(C6 to C8 and C2’ to C4’) [45]. In addition, Khatib et al. recently used computer modeling to dock the 
enzyme crystallographic structure by some 4-resorcinol derivatives with different ester chains and 
compared the experimental inhibitory IC50 values with the calculated free energy and docking energy 
[68]. The authors’ results emphasize again the importance of the 4-resorcinol skeleton in exerting 
potent tyrosinase inhibitory activity and the extent to which a lipophilic moiety, combined with the 
resorcinol skeleton, can contribute to this activity. The additional lipophilic groups affect both the 
inhibition  potency,  as  well  as  the  ability  of  the  tyrosine  to  compete  with  the  inhibitors.  Such  a 
lipophilic unit, which contains a minor bulky group, was a preferred inhibitor over a long chain or 
highly bulky functional moiety, as it may interact with the enzyme hydrophobic pocket and augment 
binding affinity. The conclusion could explain the potent inhibitory activity of prenylated chalcone 
with 4-resorcinol moiety such as kuraridin and kuraridinol described above.  
 
Stilbenes. A stilbene consists of an ethene double bond substituted with a benzyl ring on both carbon 
atoms of the double bond. Oxyresveratrol (2,4,3',5'-tetrahydroxy-trans-stilbene, Figure 4a), which was 
initially isolated from Morus alba, exhibited 32-fold more inhibitory activity than that of kojic acid 
[40].  The  inhibitor  acts  non-competitively  on  both  monophenolase  and  diphenolase  activity  of 
mushroom tyrosinase. Based on the potent inhibitory capacity, oxyresveratrol reduced pigmentation in 
melanoma cells. The melanogenesis inhibitory mechanism of the compound was proved to directly 
inhibit enzyme activity but not affect gene expression [69]. It is worth noting that oxyresveratrol also 
contains the structure of the 4-resorcinol moiety in the B ring and the 5-resorcinol moiety in the A ring 
as described in the former “chalcone” section. In fact, oxyresveratrol is 50-fold more active than its 
analog,  resveratrol  (2,3',5'-trihydroxy-trans-stilbene),  which  loses  the  4-resorcinol  moiety  in  its 
structure.  Taken  together  with  all  these  findings,  the  key  role  of  the  structural  criterion  (the  
4-resorcinol  moiety  in  the  B  ring  and  the  5-resorcinol  moiety  in  the  A  ring)  of  an  inhibitor  in 
tyrosinase  inhibition  has  been  validated  in  flavones,  chalcones,  and  stilbenes,  and  this  criterion 
becomes a golden rule for further design of a potent tyrosinase inhibitor.  
 
Following oxyresveratrol, another three hydroxystilbenes were also purified and identified as potent 
tyrosinase  inhibitors.  Chloroporin  (4-geranyl-3,5,2',4'-tetrahydroxy-trans-stilbene,  Figure  4a)  was 
purified from the heartwood of Chlorophora excelsa and displayed 14.8-fold inhibitory activity of 
kojic  acid  against  diphenolase  of  mushroom  tyrosinase  [70].  Gnetol  (2,6,3',5'-tetrahydroxy-trans-
stilbene, Figure 4a), isolated from the roots of Gnetum gnemon, exhibited 30-fold more diphenolase 
inhibitory activity of murine tyrosinase than that of kojic acid [71]. Recently, piceatannol (3,5,3',4'-
tetrahydroxy-trans-stilbene,  Figure  4a),  isolated  from  grapes  and  red  wine,  showed  32.7-fold 
antimonophenolase activity of kojic acid toward mushroom tyrosinase [72]. The hydroxyl positions of 
the structure of piceatannol, which contains o-(3',4'-)dihydroxy groups, are significantly different from Int. J. Mol. Sci. 2009, 10                       
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other naturally found hydroxystilbenes. The o-dihydroxy groups play an important role in antioxidant 
activity  (free  radical  scavenging).  In  fact,  piceatannol  has  strong  suppressive  activity  in  reactive 
species generation and enhances the reduced/oxidized glutathione ratio in cells. Hence, the inhibitory 
mechanism  of  piceatannol  on  tyrosinase  monophenolase  activity  may  be  exerted  by  both  direct 
tyrosinase inhibition and quinone products scavenging, and is not the same with that of oxyresveratrol. 
However, a detailed kinetic study of the inhibition by piceatannol is lacking. 
Aside from naturally occurring hydroxystilbenes, a number of synthetic stilbene derivatives are also 
good tyrosinase inhibitors. To examine the structure-activity relationship, a variety of hydroxystilbene 
compounds  were  synthesized  and  assayed  for  their  tyrosinase  inhibitory  activity.  The  role  of  the 
double bond between the two aromatic rings of the stilbene skeleton in the tyrosinase inhibition has 
been discussed in these studies. By comparing the diphenolase inhibitory activity of murine tyrosinase 
by cis- and trans-isomers of 3,3'-dihydroxystilbene, it was concluded that the trans-olefin structure of 
the parent stilbene skeleton is essential for inhibition [73]. Indeed, all the natural hydroxystilbenes 
possessing potent antityrosinase activity are trans-isomers. However, recently, Song et al., concluded 
the opposite: they found that the diphenolase inhibitory capacity on mushroom tyrosinase by cis-3,5-
dihydroxystilbene  was  stronger  than  that  by  its  corresponding  trans-isomer  [74].  The  reasons  to 
explain the obtainted opposite results are not clear. On the other hand, a gnetol analog, dihydrognetol, 
which loses the double bond between the two aromatic rings, exerted a greatly lowered inhibitory 
effect on diphenolase activity of murine tyrosinase [73], and it was concluded that the role of the 
double bond in the stilbene skeleton for tyrosinase inhibition is critical. In contrast, an oxyresveratrol 
analog, dihydrooxyresveratrol (Figure 4b), which also loses the double bond between the two aromatic 
rings, showed 8-fold more diphenolase inhibitory activity toward mushroom tyrosinase than its analog, 
oxyresveratrol  [75].  The  authors  suggested  that  the  higher  tyrosinase  inhibitory  activity  of 
dihydrooxyresveratrol was probably due to its bibenzyl structure, which gave more flexibility and thus 
allowed the phenolic groups to interact with the enzyme more effectively. Similar results were also 
found by both Oozeki et al. [76] and Vielhaber et al. [77]. The former authors synthesized another 
bibenzyl  analog  but  with  2,4,2',4'-tetrahydroxyl  substitution  groups  (Figure  4b)  and  identified  the 
compound  to  be  20-fold  more  active  than  kojic  acid  while  the  latter  authors  found  that  4-(1-
phenylethyl)1,3-benzenediol (Figure 4b) inhibited mushroom tyrosinase 22 times more effective than 
kojic acid. These results implied again that the double bond in the stilbene structure is not essential. 
Despite the undefined inhibitory mechanism of hydroxystilbenes, one Korean research group led by 
Chung  and  Suh  recently  successfully  synthesized  a  new  isostere  of  oxyresveratrol,  HNB  [4-(6-
hydroxy-2-naphthyl)-1,3-bezendiol,  Figure  4b],  which  exhibited  546-fold  more  inhibitory  activity 
toward monophenolase of mushroom tyrosinase than that of kojic acid [78]. HNB is also the strongest 
tyrosinase inhibitor published until now. The kinetic study demonstrated that HNB is a competitive 
inhibitor with a KI value of 4.78 to 6.21 nM. Due to the potent tyrosinase inhibitory activity, it is 
reasoned that HNB suppressed cellular tyrosinase activity and total melanin content to 27% and 35%, 
respectively, in melanoma cells at 100 M concentration, where cells maintained 87% viability [79].  
 
Coumarins.  Coumarins  are  lactones  of  phenylpropanoid  acid  with  an  H-benzopyranone  nucleus. 
Among the coumarin-type tyrosinase inhibitors, aloesin (Figure 4c) is the famous one, which is a 
natural  hydroxycoumarin  glucoside  isolated  from  Aloe  vera.  Aloesin  performed  more  inhibitory Int. J. Mol. Sci. 2009, 10                       
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activity  toward  crude  murine  tyrosinase  than  mushroom  tyrosinase  and has  been  recently  used  in 
topically applied cosmetics due to its natural source and multifunctional activity in skin care [80-81]. 
A coumarin analog, esculetin, was isolated from the seeds of Euphorbia lathyris and showed one-
quarter  of  the  antityrosinase  activity  of  kojic  acid  [82].  However,  the  compound  was  recently 
demonstrated to be a substrate of mushroom tyrosinase [83]. Another coumarin analog, 9-hydroxy-4-
methoxypsoralen  (Figure  4c),  was  isolated  from  Angelica  dahurica  and  exhibited  six  times  more 
tyrosinase inhibitory activity than that of kojic acid [84]. Recently, a new coumarin derivative, 8'-epi-
cleomiscosin A (Figure 4c), was isolated from the aerial parts of Rhododendron collettianum and 
showed  12.8-fold  diphenolase  inhibitory  activity  of  kojic  acid  toward  mushroom  tyrosinase  [85]. 
Interestingly, another purified compound, cleomiscosin A, had a structure highly similar to that of  
8'-epi-cleomiscosin A but exhibited a 14-fold decrease in tyrosinase inhibitory activity compared to 
that of 8'-epi-cleomiscosin A. The only difference between these two compounds is that the -proton 
at the position 8' for the former, where the -proton at the same position for the latter. A change in 
stereochemistry of a single proton that drastically changes the inhibitory activity of the compound is 
rarely found in the reviewed literature.  
Figure 4. Chemical structures of selected tyrosinase inhibitors belonging to stilbenes (a), 
bibenzyl derivatives (b), coumarins (c), and benzaldehyde derivatives (d). RA
a and RA
b 
have the same meanings as those of Figure 3.  
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3.2. Benzaldehyde and Benzoate Derivatives 
In the past decade, a large number of benzaldehyde and benzoate derivatives have been isolated 
from plants and identified as tyrosinase inhibitors, including benzoic acid, benzaldehyde, anisic acid, 
anisaldehyde,  cinnamic  acid,  and  methoxycinnamic  acid  from  the  roots  of  Pulsatilla  cernua  [86],  
4-substituted  benzaldehydes  from  cumin  [87],  2-hydroxy-4-methoxybenzaldehyde  from  roots  of 
Mondia  whitei  [88],  p-coumaric  acid  from  the  leaves  of  Panax  ginseng  [89],  hydroxycinnamoyl 
derivatives from green coffee beans [90], and vanillic acid and its derivatives from black rice bran [91]. 
The  aldehyde  group  is  known  to  react  with  biologically  important  nucleophilic  groups  such  as 
sulfhydryl, amino, and hydroxyl groups. The tyrosinase inhibitory mechanism of benzaldehyde-type 
inhibitors comes from their ability to form a Schiff base with a primary amino group in the enzyme 
[92-93]. In contrast, benzoate inhibits tyrosinase by a copper chelating mechanism and belongs to a 
typical  HA-type  acid  tyrosinase  inhibitor,  whose  inhibitory  mechanism  involves  the  interaction 
between the non-ionized form of the inhibitor and the copper in the active site of the enzyme [94]. In 
terms of inhibitory strength, all the naturally occurring benzaldehyde and benzoate derivatives listed 
above showed only weak-to-moderate tyrosinase inhibitory activity while none are stronger than kojic 
acid.  Recently,  flourobenzaldehydes  [95],  methyl  trans-cinnamate  [96],  salicylic  acid  [97], 
hydroxybenzaldehydes [98], and 4--D-glucopyranosyloxybenzoate [99] were also proved to be weak 
tyrosinase inhibitors with one to two orders of magnitude of lower antityrosinase activity than that of 
kojic acid. The most potent natural inhibitor of benzaldehyde type was not identified in plants but in a 
fungus. Protocatechualdehyde (Figure 4d) was isolated from the fruiting body of Phellinus linteus and 
exhibited 7.8-fold more tyrosinase inhibitory activity than that of kojic acid [100]. It is worth noting 
that its analog, protocatechuic aldehyde, with two methoxyl groups replacing the two hydroxyl groups 
showed one order of magnetite of lower activity than that of protocatechualdehyde [101]. Moreover, 
another analog, protocatechuic acid isolated from black rice bran with a benzoate skeleton, showed 
another one order of magnetite of lower activity [91]. Thus, it is indicated that both the o-dihydroxyl 
group and the aldehyde group of the protocatechualdehyde structure play important roles in exerting 
its inhibition activity. On the other hand, to improve the inhibitory strength of the benzaldehyde-type 
inhibitors, some derivatives were chemically synthesized and assayed to determine their inhibitory 
activity.  4-Vinylbenzaldehyde  [102],  4-alkylbenzaldehyde  [103-104],  2-hydroxy-4-isopropyl-
benzaldehyde  [105],  3,4-dihydroxybenzaldehyde-O-ethyloxime  (Figure  4d)  [106],  and  4-butyl-
benzaldehyde thiosemicarbazone  [107] were successfully synthesized and showed 35-, 100-, 350-, 
1500-,  and  2000-fold,  respectively,  more  potent  activity  than  that  of  the  precursor  benzaldehyde. 
However, advanced data for cell cytotoxicity and cellular melanogenesis inhibition are lacking for 
these improved benzaldehyde derivative inhibitors.  
Gallic acid (3,4,5-trihydroxybenzoate) has been isolated and identified as a tyrosinase inhibitor 
from many plants, and its inhibitory mechanism together with those of its ester derivatives has been 
well studied by Kubo et al. [108-110]. They found that gallic acid inhibited diphenolase activity of 
mushroom tyrosinase with a IC50 value of 4500 M, which is 100-fold lower than that of kojic acid. In 
addition,  gallic  acid  itself  and  its  short  alkyl  chain  esters  (<C10)  were  oxidized  by  mushroom 
tyrosinase as substrates, but the long-chain alkyl chain esters (>C10) inhibited the enzyme without 
being  oxidized.  Gallic  acid  was  also  found  to  be  very  toxic  to  melanoma  cells  with  cytotoxicity Int. J. Mol. Sci. 2009, 10                       
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comparable to that of hydroquinone [111]. Recently, Nithitanakool et al. isolated both gallic acid and 
its methyl derivative from seed kernels of Mangifera indica, and determined that both compounds 
were  poor  inhibitors  against  diphenolase  activity  of  mushroom  tyrosinase  with  300-  and  30-fold, 
respectively, lower activity than that of kojic acid [112]. These results were consistent with previous 
studies. In spite of the poor inhibitory activity of gallic acid itself, some compounds with gallate 
moiety were found to inhibit mushroom tyrosinase more effectively. Some flavonoids with gallate 
moiety bonded to the 3-hydroxyl position, including GCG [(+)-gallocatechin-3-O-gallate] and EGCG 
[(-)-epigallocatechin-3-O-gallate], were isolated from green tea leaves and showed stronger inhibitory 
activity  [113].  Similarly,  three  tyrosyl  gallates  were  synthesized  and  showed  stronger  inhibitory 
activity [114]. In recent times, 1,2,3,4,6-pentagalloylglucopyranose isolated from the seed kernels of M. 
indica [112] and the roots of Paeonia suffruticosa [115], respectively, was found to be 16-fold more 
active than gallic  acid and  inhibited monophenolase  activity  of mushroom tyrosinase with a non-
competitive mode.  
Figure  5.  Chemical structures of selected tyrosinase inhibitors belonging to long-chain 
lipids (a) or steroids (b). RA
a and RA
b have the same meanings as those of Figure 3. 
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3.3. Long-chain Lipids and Steroids 
Recently,  several  lipids  were  purified  from  natural  sources  and  exhibited  tyrosinase  inhibitory 
activity. A triacylglycerol, trilinolein (Figure 5a), was isolated from sake lees, which are byproducts of 
sake production, and proved to be as potent as kojic acid for inhibition of diphenolase activity of 
mushroom tyrosinase [116]. Based on the findings, including inability of copper chelating, lack of free 
radical  scavenging,  and  kinetically  non-competitive  inhibition  of  the  inhibitor,  the  inhibitory 
mechanism  was  proposed  by  binding  of  the compound to  some  site  of  the tyrosinase,  except  the 
catalytic site. A glycosphingolipid, soyacerebroside I, which is composed of a sphingoid base skeleton, 
an amide aliphatic long-chain fatty acid, and a -glucopyranose moiety, was isolated from the leaves 
of Guioa villosa and found to inhibit monophenolase and diphenolase activity of mushroom tyrosinase Int. J. Mol. Sci. 2009, 10                       
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with half-activity of kojic acid [117] while another glycosphinogolipid, cerebroside B, from Phellinus 
linteus showed no inhibitory activity against the enzyme [100]. In addition, trans geranic acid from 
Cymbopogon citrates (lemongrass) was recently identified as a tyrosinase inhibitor but with only one-
tenth of the inhibitory activity of kojic acid [118].  
In addition to long-chain lipids, some steroids were also determined to be tyrosinase inhibitors. 
Many studies in this field were contributed by the research group of Choudhary and Khan. Three 
steroids  isolated  by  these  authors  from  the  aerial  parts  of  Trifolium  balansae  showed  higher 
diphenolase inhibitory activity toward mushroom tyrosinase than that of kojic acid [119]. Among the 
steroids, stigmast-5-ene-3,26-diol (Figure 5b) was 7-fold more active. The authors also found that a 
long-chain  ester,  2(2S)-hydroxyl-7(E)-tritriacontenoate  (Figure  5a),  from  Amberboa  ramose 
exhibited 12.3-fold more inhibition against the diphenolase activity of mushroom tyrosinase compared 
to the standard kojic acid [120]. On the other hand, the derivative containing a D-galactopyranosyl 
moiety at C2 was found to lose one order of magnitude on its tyrosinase inhibitory activity. Like most 
cases of tyrosinase inhibitors, the presence of the bulky and hydrophilic D-galactopyranosyl moiety 
interferes  with  the  entrance  of  the  molecule  into  the  active  site  of  the  enzyme,  thus  reducing  its 
inhibitory activity. From the same plant, eight cycloartane triterpenoids were isolated at the same time. 
A  triterpenoid,  3,21,22,23-tetrahydroxycycloart-24(31),25(26)-diene  (Figure  5b),  exhibited  an 
extremely  potent  inhibition  (12.6-fold)  against  diphenolase  activity  of  mushroom  tyrosinase  when 
compared with kojic acid [121]. The same research group also purified some triterpenoid glycosides 
from  the  roots  of  Astragalus  taschkendicus.  However,  the  triterpenoid  glycosides  showed  only 
inhibitory  activity  equal  to  that  of  kojic  acid  against  mushroom  tyrosinase  [122].  In  advance, 
Choudhary  and  Khan  purified  nine  pentacyclic  triterpenes  from  the  aerial  part  of  the  plant 
Rhododendron collettianum, and all the triterpenes showed potent diphenolase inhibitory activity of 
mushroom tyrosinase. Among them, arjunilic acid (Figure 5b) was the strongest tyrosinase inhibitor, 
which was 16.7-fold inhibitory activity of kojic acid [123]. In addition to triterpenoids, the authors also 
purified many diterpenoids from the aerial parts of Aconitum leave [124]. However, most diterpenoids 
did not inhibit tyrosinase activity. Only one compound, lappaconitine hydrobromide, revealed activity 
similar to that of kojic acid [125]. Similar to the diterpenoids, few monoterpenoids were found to be 
strong tyrosinase inhibitors; only a monoterpenoid, crocusatin-K, isolated from the petals of Crocus 
sativus, was proved to display inhibitory activity equal to that of kojic acid [126]. More recently, Wu 
et al. isolated four new sesquiterpenes from the leaves and stems of Chloranthus henryi [127] and two 
new sesquiterpenes dimmers from the leaves of Chloranthus tianmushanensis [128], and found that 
these sesquiterpenes showed either no or weak tyrosinase inhibitory activity. In addition to the original 
steroids  from  plants,  two  11-hydroxylated  steroid  metabolites  were  isolated  from  the  fungus 
Cunninghamella elegans cultivations feeding with 17-ethynyl- or 17-ethylsteroids (Figure 5b) and 
showed 2.9- and 9.8-fold higher tyrosinase inhibitory activity, respectively, than that of kojic acid 
[129].  Regarding  the  difficult  permeability  of  skin,  these  hydrophobic  steroid  or  long-chain  lipid 
inhibitors seems to have superior potential in the development as skin-whitening agents due to their 
easier cellular permeability. However, all these lipid inhibitors are lack of cellular or clinical assays for 
determining their depigmentation activity and remain less utilized by the cosmetics industry until now.  Int. J. Mol. Sci. 2009, 10                       
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3.4. Other Natural and Synthetic Inhibitors 
Other inhibitors from natural sources. Anthraquinones from different plant sources have been widely 
used  since  ancient  times  due  to  their  laxative  and  cathartic  properties.  In  addition,  this  class  of 
compounds has shown a wide variety of pharmacological activities, such as antiinflammatory, wound 
healing,  analgesic,  antipyretic,  antimicrobial,  and  antitumor  activities.  Recently,  an  anthraquinone, 
physcion (1,8-dihydroxy-2-methoxy-3-methylanthraquinone, Figure 6a), was found to show similar 
tyrosinase inhibitory activity with that of kojic acid [130]. Interestingly, another anthraquinone, 1,5-
dihydroxy-7-methoxy-3-methylanthraquinone  (Figure  6a),  with  hydroxyl  and  methoxyl  groups  at 
different positions compared with those of physcion exhibited a 72-fold increase on antityrosinase 
activity  [131].  Therefore,  it  is  worthy  to  systematically  evaluate  the  structure-activity  relationship 
between the functional groups attached to the anthraquinone skeleton and the antityrosinase activity. In 
addition, many lignans isolated from the roots of Vitex negundo showed higher tyrosinase inhibitory 
activity than kojic acid, while the most active lignan from the plant was (+)-lyoniresinol (Figure 6a), 
whose activity was 5.2-fold higher than that of kojic acid [132]. In addition to the inhibitors from 
plants,  marine  beings  inhabit  virtually  any  environment in  the sea, and  they have  been  shown to 
produce novel substances with  utilities in fine chemicals, drug, and cosmetics products, including 
tyrosinase inhibitors. One phloroglucinol derivative, dieckol, was isolated from a marine brown alga, 
Ecklonia stolonifera, and displayed three times more activity than that of kojic acid [133]. In addition, 
a  marine-derived  fungus  Myrothecium  sp.  was  found  to  contain  6-n-pentyl--pyrone  (Figure  6a), 
which was a potent tyrosinase inhibitor with 9.6-fold inhibitory activity of kojic acid [134]. Recently, 
another tyrosinase inhibitor was purified from a marine bacteria, Trichoderma viride strain H1-7, and 
showed  competitive  inhibition  toward  monophenolase  activity  of  mushroom  tyrosinase  through 
binding to a copper active site of the enzyme [135].  
Figure 6. Chemical structures of other tyrosinase inhibitors from natural (a) or synthetic (b) 
sources. RA
a and RA
b have the same meanings as those of Figure 3. 
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Other inhibitors from synthetic sources. For smaller molecules, it is easier to rationally design the 
structures of the molecules by a chemically synthetic method. Improving the tyrosinase inhibitory Int. J. Mol. Sci. 2009, 10                       
 
 
2459 
activity of a known inhibitor by properly changing the substitute groups on its structure is expected. N-
Phenylthiourea (PTU, Figure 6b) is a well-known inhibitor for inhibiting diphenolase enzyme that 
belongs to the type-3 copper protein group. The sulfur atom of the compound binds to both copper ions 
in the active site of the enzyme and blocks enzyme activity [136]. Criton and Le Mellay-Hamon 
synthesized a series of analogs of N-phenylthiourea and put into assays of the inhibitory activity of the 
analogs against diphenolase activity of mushroom tyrosinase. They found that when the amino group 
and  the  sulfur  moieties  of  N-phenylthiourea  were  replaced  by  N-hydroxylamine  and  oxygen, 
respectively,  the  resulting  compound  (Figure  6b)  exhibited  six  times  more  activity  than  that  of  
N-phenylthiourea [137]. In another study, the same authors synthesized N-(phenylalkyl)cinnamides 
derived  from  the  coupling  cinnamic  acid  with  phenylalkylamines  and  found  that  two  synthetic 
compounds showed higher inhibitory activity than that of kojic acid [138]. Similarly, Kang et al. 
designed a series of compounds by combining the structures of two putative tyrosinase inhibitors, kojic 
acid and caffeic acid, to form new inhibitors, which showed antidiphenolase activity equal to that of 
kojic acid toward mushroom tyrosinase but enhanced depigmentation activity in melanoma cells [139]. 
In addition, Shiino et al. synthesized analogs of cupferron, which is a well-known metal chelating 
agent and inhibits competitively both monophenolase and diphenolase activity of mushroom tyrosinase 
[140],  and  found  that  N-substituted-N-nitrosohydroxylamines  inhibited  mushroom  tyrosinase  by 
interacting with the copper ions at the active site of the enzyme [141]. As removal of nitroso or 
hydroxyl moiety completely diminished the inhibitory activity, both functional groups were suggested 
to be essential for chelating activity. Among the derivatives, the authors found that N-hydroxybenzyl-
N-nitrosohydroxylamines showed the best inhibitory activity, which is comparable with that of kojic 
acid  [142].  In  advance,  they  recently  reported  that  these  N-substituted-N-nitrosohydroxylamines 
inhibited mushroom tyrosinase in a pH-dependent manner due to the non-ionized, electrically neutral 
form of the compounds [143]. Another research group led by Khan also did a lot of successful work 
for developing new tyrosinase inhibitors by chemically synthetic methods. The discovered new types 
of inhibitors included sildenafil [144], oxadiazole [145], oxazolones [146], and tetraketones types [147] 
(Figure 6b). The strongest inhibitor of each type list above was between 7- and 14-fold stronger than 
kojic acid. On the other hand, Kim et al. focused on developing new type inhibitors containing a 
selenium atom, which is an essential biological trace element and an integral component of several 
enzymes. The use of selenium as a nutritional supplement has been popularized recently due to its 
potential roles as an antioxidant and an anticancer agent. The authors demonstrated that some 1,3-
selenazol-4-one  derivatives  [148],  selenourea  derivatives  [149],  and  selenium-containing 
carbohydrates  [150]  possessed  inhibitory  activity  similar  to  that  of  kojic  acid  against  diphenolase 
activity  of  mushroom  tyrosinase.  However,  these  selenium-containing  derivatives  were  applied  in 
melanogenesis inhibition assays in melanoma cells; most compounds showed both cytotoxicity and 
depigmenting effects and had restrictions in applications to cosmetics or foods.  
 
Some  simple  phenyl  and  biphenyl  compounds  were  also  synthesized  and  identified  as  potent 
tyrosinase  inhibitors.  4,4'-Dihyldroxybiphenyl  (Figure  6b)  showed  12-fold  more  monophenolase 
inhibitory activity of mushroom tyrosinase than that of kojic acid with a competitive inhibition mode 
[151]  while  its  glucoside  derivatives  from  the  fruit  of  Pyracantha fortuneana displayed  only  low 
inhibitory activity [152]. In addition to directly inhibiting tyrosinase activity, 4,4'-dihyldroxybiphenyl Int. J. Mol. Sci. 2009, 10                       
 
 
2460 
was  also  found  to  suppress  several  cellular  key  parameters  in  the  melanogenic  pathway  by 
downregulating  the  cAMP-dependent  protein  kinase  K  signaling  pathway  and  decreasing  gene 
expression  of  microphthalmia  transcription  factor,  which  in  turn  suppressed  tyrosinase  expression 
[153]. In addition, S-phenyl N-phenylthiocarbamate (Figure 6b) [154] and 4-(2',4'-dihydroxyphenyl)-
(E)-3-buten-2-one [155] were recently found to be 44-fold and 6-fold, respectively, more active than 
kojic acid toward diphenolase activity of mushroom tyrosinase. However, although huge numbers of 
synthetic  inhibitors  were  successful  in  inhibiting  tyrosinase  activity,  few  have  been  confirmed  in 
melanogenesis inhibiting activity in cells or skin models.  
3.5. Irreversible Inactivators 
In  contrast  to  the  huge  number  of  reversible  inhibitors  has  been  identified,  rarely  irreversible 
inhibitors  of  tyrosinase  were  found  until now. These irreversible inhibitors, which are also called 
specific inactivators, can form irreversibly covalent bond with the target enzyme and then inactivate it. 
However, the tyrosinase irreversible inhibitors are different from non-specifically irreversible enzyme 
inactivators such as acids or bases, which destroy all protein structures. Instead, they are generally 
specific for tyrosinase and do not inactivate all proteins; they work by specifically altering the active 
site of the enzyme. The substrate reaction kinetics method described by Tsou has been widely used in 
studies of inactivation of various enzymes by different types of inactivation or inhibitions [156]. As 
shown in Scheme 2, irreversible inhibitors form a reversible non-covalent complex with the enzyme 
(EI or ESI), and this then reacts to produce the covalently modified “dead-end complex” Ei. The rate at 
which Ei is formed is called the inactivation rate or kinact. It is worth noting that irreversible inhibitors 
display time-dependent inhibition, and their potency therefore cannot be characterized by an IC50 value. 
This is because the amount of active enzyme in a given concentration of irreversible inhibitor will be 
different depending on how long the inhibitor is pre-incubated with the enzyme.  
Scheme 2. Reaction mechanism of irreversible inhibitors. E and Ei are the enzyme and the 
inactivated  enzyme,  respectively;  S,  I,  and  P  are  the  substrate,  inhibitor,  and  product, 
respectively; ES, EI and ESI are the intermediates. 
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Captopril (Figure 7), an antihypertensive drug [(2S)-1-(3-mercapto-2-methylpropionyl)-L-proline], 
forms  both  a  copper-captopril  complex  and  a  disulfide  bond  between  captopril  and  cysteine-rich 
domains  at  the  active  site  of  tyrosinase  [157].  Accordingly,  the  drug  is  able  to  prevent  melanin 
formation by irreversibly inhibiting monophenolase and diphenolase activity of mushroom tyrosinase 
in a non-competitive and competitive manner, respectively, as well as by scavenging the generated o-
quinones to form a colorless conjugate. The kinetic study showed that the value of the rate inactivation 
constant  kinact  was  1.98  x  10
-4  M
-1s
-1.  H2O2  is  also  known  as  an  inactivator  of  several  copper-
containing enzymes, such as dopamine -monooxygenase [158] and mushroom tyrosinase [159]. It 
was proposed that high concentrations of H2O2 could oxidize a methionine residue in position 374 of 
the  mushroom  tyrosinase  active  site  to  methionine  sulfoxide,  and  this  event  would  inactivate  the 
enzyme  [160].  Chen  et  al.  discovered  two  other  irreversible  inhibitors  of  tyrosinase,  including 
cetylpyridinium chloride [161] and 3,5-dihydroxyphenyl decanoate [162] (Figure 7). The fluorescence 
spectroscopic results demonstrated that cetylpyridinium chloride can bind to the tyrosinase molecule 
and induce enzyme conformational changes, which undergo a slow irreversible inactivation of the 
enzyme. The kinetic study determined the values of the inactivation constants of the inhibitor toward 
the free enzyme and enzyme-substrate complex to be 3.957 and 6.078 x 10
-3 s
-1, respectively. On the 
other  hand,  the  inhibition  mechanism  of  3,5-dihydroxyphenyl  decanoate  was  irreversible  and 
competitive/uncompetitive mixed type inhibition with varied inactivation constants ranging from 1.93 
to  7.912  x  10
-3  s
-1.  Recently,  p-hydroxybenzyl  alcohol  showed  binding  capability  of  mushroom 
tyrosinase  and  irreversibly  inhibited  the  enzyme  [163].  It  was  demonstrated  that  p-hydroxybenzyl 
alcohol  (Figure 7) exhibited an inhibitory effect on melanogenesis in melanoma cells at non-cytotoxic 
concentrations. The suppression of melanin synthesis by the compound was attributed to its behavior 
in directly inhibiting cellular tyrosinase activity without effects on the expression level of tyrosinase 
mRNA. In another study, it is very interesting to find that hen egg white lysozyme (HEWL) inhibited 
mushroom  tyrosinase  with  a  reversibly  and  irreversibly  mixed  inhibition  mechanism  [164].  The 
authors suggested that HEWL binds to glycoside linkage in tyrosinase and induces its conformational 
change. Some of the bound HEWL continues to non-specifically cleavage glycosidic linkages and 
induces irreversible inhibition while the other portion of the HEWL-tyrosinase complex restored the 
diphenolase activity of tyrosinase after depletion of HEWL.   
Figure 7. Chemical structures of irreversible tyrosinase inhibitors. 
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Among the irreversible inhibitors, suicide substrates belong to a special class.  It is known that 
tyrosinase could be irreversibly inhibited by its o-diphenol substrates, such as L-dopa and catechol 
[165].  These  substrates  were  also  named  suicide  substrates  or  mechanism-based  inhibitors.  The 
mechanism of the suicide substrate has been extensively studied by Waley [166], who proposed a 
simple branched reaction pathway as Scheme 3, in which an intermediate Y may give either an active 
enzyme and product, or an inactive enzyme. In the scheme, the intermediate Y has a choice of reaction, 
governed by the partition ratio r, where r = k+3/k+4. The r value is called the molar proportion for 
inactivation, i.e., the number of molecules of inhibitors required to completely inactivate one molecule 
of the enzyme, and may be determined by plotting the fractional activity remaining against the ratio of 
the initial concentration of inhibitor to that of enzyme. The intercept on the abscissa is 1 + r in the plot, 
when r > 1 [167]. As in general irreversible inhibitors, the inhibitory strength of a suicide substrate is 
also not determined by an IC50 value but expressed by its r value, where a smaller r value of a suicide 
substrate means fewer inhibitor molecules are needed to inactivate all enzyme activity and being more 
powerful inhibition.  
Scheme  3.  Action  mechanism  for  suicide  substrate.  E  and  Ei  are  the  enzyme  and 
inactivated enzyme, respectively; P is the product; X is the first intermediate, and Y is 
another intermediate. 
 
In addition to the kinetic reaction mechanism, Land et al. recently proposed a model to explain the 
detailed molecular reaction mechanism of the suicide inactivation of tyrosinase based on the chemical 
structures  of  substrates  and  crystallographic  tyrosinase  [168].  In  their  model,  the  inactivation  of 
tyrosinase during catechol oxidation is due to the catechol being capable of an alternative “cresolase” 
(monophenolase) presentation (Figure 8). Oxygen addition to the catechol ring by cresolase activity 
generates  an  intermediate  product  that  can  undergo  deprotonation  and  reductive  elimination.  This 
deprotonation leads to the inactivation of the enzyme by formation of a copper atom, which does not 
bind to the histidine ligands. According to the model, suicide inactivation of tyrosinase depends on 
anomalous catechol oxidation and the consequence of the formation of zero-valency copper. Their 
model can explain well the experimental observation that half of the copper is lost from the active site 
during  catechol  inactivation.  Moreover,  the  authors  in  advance  used  hplc/mass  to  identify  the 
hydroquinone product in the suicide inactivation of mushroom tyrosinase with 4-methylcatechol as a 
substrate [169]. Very interestingly, tyrosinase has the following two unique properties: (1) Tyrosinase 
is able to catalyze oxidations of both monophenols (cresolase activity) and diphenols (catecholase 
activity)  to  o-quinones,  and  (2)  tyrosinase  exhibits  suicide  inactivation  during  the  oxidation  of 
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catechols. In the Land cresolase-dependent model, the two properties are neatly connected, and suicide 
inactivation is the result of catecholic substrates being processed by the cresolase route.  
Figure  8.  Molecular  reaction  mechanism  of  suicide  inactivation  of  tyrosinase  by  the 
oxidation of an o-diphenol substrate. The curly arrows shows the effect of deprotonation 
leading to the reduction of copper from bivalent to zero-valent form, elimination of an o-
quinone and inactivated tyrosinase [168].  
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Although  both  the  kinetic  and  the  molecular  reaction  mechanism  of  suicide  inactivation  of 
tyrosinase have been well studied, potent suicide substrates have rarely been discovered. Recently, we 
found that two isoflavones, 7,8,4'-trihydroxyisoflavone and 5,7,8,4'-tetrahydroxyisoflavone (Figure 3h), 
were  potent  and  unique  suicide  substrates  of  mushroom  tyrosinase  with  low  partition  ratios,  low Int. J. Mol. Sci. 2009, 10                       
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Michaelis constants, and high maximal inactivation rate constants [54]. The partition ratios between 
molecules of suicide substrate in the formation of the product and in the inactivation of the enzyme 
were  determined  to  be  81.7  and  35.5,  for  7,8,4'-trihydroxyisoflavone  and  5,7,8,4'-tetrahydroxy-
isoflavone, respectively. In the reviewed literature, 5,7,8,4'-tetrahydroxyisoflavone is the most potent 
suicide substrate of mushroom tyrosinase until now and has high potential in application as a skin-
whitening agent. This compound was in advance creamed in the proper condition [170] and showed 
higher  depigmenting  activity  than  that  of  ascorbic  acid  2-glucoside  (AA2G)  in  an  in  vivo  assay 
conducted with 60 volunteers by our laboratory (unpublished data).  
4. Conclusions 
The commercial availability of mushroom tyrosinase plays a critical role in tyrosinase inhibitor 
studies, and most research has been conducted with this enzyme, which is well studied and easily 
purified  from  the  mushroom  A.  bisporus.  No  matter  in  terms  of  inhibitory  strength,  inhibitory 
mechanism, chemical structures, or the sources of the inhibitors, the search for new inhibitors based on 
mushroom tyrosinase has been so successful that various different types of inhibitors have been found 
in the past 20 years. This success is also based on several fundamental studies in different fields, such 
as the early finding and the detailed study of tyrosinase as key in melanin biosynthesis, and the deep 
research into the biochemical, kinetic, reaction mechanistic, and structural aspects of the enzyme.  
In spite of this success, it is obvious that much work in this field is still needed. First of all, the 
commonly used mushroom tyrosinase has some limitations related to the applications of the mushroom 
tyrosinase inhibitors for human use due to the differences between the fungal tyrosinase and the human 
one. The mushroom tyrosinase is a cytosol enzyme while the human tyrosinase is membrane bonded 
[9]. In addition, mushroom tyrosinase is a tetramer in contrast to the monomer type of the human 
enzyme,  which  is  highly  glycosylated  during  its  complex  maturation  process  [21].  However, 
information  regarding  the  discovered  inhibitors  to  human  tyrosinase  is  very  limited;  thus,  the 
biochemical  information  related  to  kinetic  and  mechanistic  characterizations  and  to  the  structure 
activity relationship between the inhibitors and the human tyrosinase needs further elucidation. To date, 
no tyrosinase inhibitory study has been performed with human tyrosinase due to the lack of a purified 
enzyme. Although some studies used a crude extract of human melanocytes as the enzyme source, it is 
not possible to study the detailed kinetic and mechanistic characterizations of the inhibitors to the 
specific enzyme in the very complex system. As the primary genetic information of human tyrosinase 
has been known, utilizing modern genetic engineering to produce recombinant human tyrosinase with 
suitable properties for easier purification could be possible. Using the purified human tyrosinase to 
elucidate inhibitory study will aid us considerably in developing the next generation of tyrosinase 
inhibitors. Moreover, the easier availability of human tyrosinase is also important for the resolution of 
the  X-ray  crystallographic  structure  of  the  enzyme.  Nearly  all  molecular  docking  experiments  of 
tyrosinase inhibitors were performed with the recently resolved crystallographic structure of tyrosinase 
from Streptomyces glaucescens [20]; however, the membrane-bonded property of human tyrosinase is 
expected to show something different in the enzyme structure, which is the prime criterion for inhibitor 
binding. Thus, the X-ray crystallographic structure of human tyrosinase is also needed and can shed Int. J. Mol. Sci. 2009, 10                       
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more light on the action mechanism of human tyrosinase and will be helpful in designing more suitable 
tyrosinase inhibitors for human use.  
On the other hand, the use of the inhibitors is primary in the cosmetic industry due to their skin-
whitening effects. Since a huge number of tyrosinase inhibitors have been developed, clarifying the 
validation of these inhibitors in skin-whitening efficiency has become more urgent. Most inhibitors 
have rarely been incorporated in topically applied cosmetics or cosmeceuticals, often due to a lack of 
parallel human clinical trials. In addition, most tyrosinase inhibitors listed above are not currently 
commercially available, especially those from natural sources, and this limits their further evaluation 
in an in vivo study, where usually a large amount is needed for a tested inhibitor. In conclusion, more 
concrete studies of the found inhibitors with a human clinical point of view are required, and in our 
experience, this often needs the help and cooperation of cosmetic or biotechnology companies.  
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